nootropic0 listings

TAK-653

TAK-653 (NBI-1065845 / Osavampator)

AMPA receptor potentiator. Mood and cognition research.

Mood researchCognitive research

/ research index

The research base

Research Maturity

★★★☆☆

3/5 — Volume of studies

Evidence Strength

★★★☆☆

3/5 — Quality of evidence

Researched for mood research.

/ mechanism of action

How it works

AMPA receptor positive modulator studied for treatment-resistant depression.

/ research dosing

Common research protocols

Range

Research-stage (low mg)

Frequency

Daily, oral

Route

Oral

Cycle

Research courses

Research notes

Clinical interest for depression via AMPA potentiation. Dosing emerging.

References

PMID: 35546966 →

FOR RESEARCH USE ONLY. Doses listed are compiled from published research literature, FDA-approved drug labels, and well-documented research community practice. Not medical advice.

/ standalone use

As a solo compound

Standalone oral research compound.

/ side effects

What to know

Generally well-tolerated; see research notes.

/ timeline

Realistic expectations

Weeks

FOR RESEARCH USE ONLY. TAK-653 is intended for laboratory research and not for human consumption.